Rosalía Fernández‐Calle

This paper identifies Galectin-3 as a key regulator of amyloid-beta aggregation and microglial dysfunction in Alzheimer's disease, showing its role in neurotoxicity and potential as a therapeutic target.

This study shows that early-life immune activation in 5xFAD mice alters microglial responses and reduces Aβ pathology, with effects on cytokine levels and memory deficits.

This study shows that palmitate exposure causes microglia to change their metabolism and release EVs that affect behavior and metabolism in mice.